ArticleLancet (London, England)2017
J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer.
Justin F Gainor et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleLancet (London, England)2017
Justin F Gainor et al.PubMed ↗Publisher ↗
No numbers read from the abstract.